Evidence Evaluation in Rare Disease Guidelines : A Methodological Perspective

Bolz-Johnson, MattKenny, ThomasGaasterland, CharlotteOmar, Muhammad ImranEngels, Manonvan Eeghen, Agniesden Uijl, IrisIrvine, Willemijn2025-12-182025-12-10Bolz-Johnson, M, Kenny, T, Gaasterland, C, Omar, M I, Engels, M, van Eeghen, A, den Uijl, I & Irvine, W 2025, 'Evidence Evaluation in Rare Disease Guidelines : A Methodological Perspective', Rare Disease and Orphan Drugs Journal, vol. 4, 35. https://doi.org/10.20517/rdodj.2025.292771-2893https://hdl.handle.net/2164/26553Thank you to European Reference Networks & the EAU Guideline Office for their support and contribution to the webinar.586659engrare diseasesclinical guidelinesevidence synthesismethodologyR MedicineSupplementary DataDASREvidence Evaluation in Rare Disease Guidelines : A Methodological PerspectiveJournal article10.20517/rdodj.2025.29